Autologous Adipose Derived Mesenchymal Cell Therapy(Regeneris Medical)

自体脂肪来源的间充质细胞疗法（Regeneris Medical）

Report date: 2023/01/12 15:46:27

Base Information

Drug NameAutologous Adipose Derived Mesenchymal Cell Therapy(Regeneris Medical)
Drug Alias NameAutologous Adipose Derived Mesenchymal Cell
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRegeneris Medical Inc
China Registration ClassN/A

Develop Information

Active CompaniesRegeneris Medical Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A